Platform
Features
Pricing
0 followers
Urovant Sciences, innovations in urology. Our lead therapeutic candidate is vibegron (RVT-901), an investigational oral β3-adrenergic agonist
Industries
Headquarters
Employees
Links
James Robinson
33 members
10 members
5 members
9 members
Immunome
2 followers
Thermo Fisher Scientific
155 followers
BeiGene
19 followers
Cytiva
10 followers
Merck
211 followers
Tessera Therapeutics
Vial
5 followers
Ventyx Biosciences
1 follower
Pyxis Oncology
Mineralys Therapeutics
Thrive Capital
26 followers
Explore companies